The chromosomally-encoded aminoglycoside N-acetyltransferase, AAC(2')-Ic, of
INTRODUCTION
Aminoglycosides are natural or semisynthetic, broad-spectrum bactericidal compounds consisting of a central six-membered amino cyclitol ring linked to two or more deoxy-amino sugars by glycosidic bonds. Aminoglycosides were among the first antibiotics discovered and are clinically used in the treatment of severe Gram-positive and Gram-negative bacterial infections. Their mechanism of action is the inhibition of bacterial protein synthesis by binding to the small ribosomal subunit, and additionally, they are also capable of directly disrupting the integrity of the outer membrane of Gram-negative bacteria by displacing divalent cations bridging adjacent LPS molecules (1) (2) (3) (4) . The emergence of growing numbers of resistant strains has somewhat reduced the utility of aminoglycosides in empiric therapies (5) . Resistance to aminoglycosides can arise by three distinct mechanisms: (i) alteration of ribosomal RNA and small ribosomal subunit protein binding sites, (ii) decreased uptake and/or accumulation of the drug in bacteria due to changes in the permeability of the outer membrane or active efflux, and most commonly (iii) enzymatic detoxification of the drug (6) (7) (8) (9) (10) (11) (12) . Three different types of enzymatic modification of the drug include O-phosphorylation, O-nucleotidylation and Nacetylation. Expression of genes encoding these enzymes is either by acquisition of foreign DNA (plasmid born) or by overexpression of a housekeeping gene with modifying activity (13) (14) (15) . Aminoglycoside N-acetyltransferases (AAC) use acetyl-coenzyme A (acetyl-CoA) as the acetyl group donor and are grouped into four classes: AAC(1), AAC(2'), AAC(3) and AAC (6') based on the site of their regioselective acetylation of the aminoglycoside. Members of the AAC(6') class are the most common in nature and there have been several kinetic and mechanistic studies reported on them (16) (17) (18) (19) . The only other enzyme subjected to a rigorous kinetic analysis has been gentamicin acetyltransferase, AAC(3)-I (20, 21) . 6 by standard PCR techniques using the oligonucleotides AS1(5'-ATTCCATATGCACA CCCAGGTACACACGG-3') and AA1-(5'-GCGGAATTCTTACCAGACGTCGCCCGC-3') containing the underlined NdeI and EcoRI restriction sites shown, respectively. The PCR fragment was cloned into pET-23a(+) and expressed in the E. coli strain BL21(DE3). For shake flask growth, 1 l of LB-medium supplemented with carbenicillin (50 µg/ml) was inoculated with 10 ml of an overnight culture and incubated at 37°C. The culture was grown to mid-log phase (A 600 ∼1.0), cooled to 20°C for 15 min, induced with 0.2 mM IPTG, and further incubated for 8-10 h at 20°C . All purification procedures were carried out at 4°C. The cells were collected by centrifugation at 10000 rpm and resuspended in buffer A (25 mM TEA, pH 7.8, 50 mM NaCl, 1 mM EDTA, 1 mM DTT) containing protease inhibitors (Roche), lysozyme (0.2 µg/ml), and DNase I (1µg/ml) and stirred for 20 min. The cells were then lysed by passage through a French Press (1200 psi) and cell debris removed by centrifugation at 16000 rpm for 40 min.
Solid ammonium sulfate was then added to the supernatant to a final concentration of 0.85 M.
The mixture was stirred for 1 hour and centrifuged at 20000 rpm. The supernatant was further treated with solid ammonium sulfate to a final concentration of 1.6 M. After stirring for 2 hours, the pellet, separated by centrifugation at 20000 rpm, was resuspended in buffer B (25 mM TEA containing 1 mM DTT, 1 mM EDTA, 50 mM NaCl, and 0.5 M (NH 4 ) 2 SO 4 ). After extensive dialysis, the precipitate was removed by centrifugation at 20000 rpm for 10 min. The clear supernatant was then loaded onto a phenyl-Sepharose (Amersham Pharmacia Biotech) column pre-equilibrated with buffer B. The bound proteins were eluted with a linear 0.5 to 0 M ammonium sulfate gradient at a flow rate of 1 ml/min. The active fractions were pooled, solid 7 ammonium sulfate was added to a final concentration of 0.5 M, and the solution rechromatographed on phenyl-Sepharose as above. The enzyme after this step was found to be > 90% pure as assessed by SDS-PAGE. The enzyme preparation was stored in 50% glycerol at -20°C for long term storage and retained full activity for 8-10 months Protein Estimation: Protein concentrations were estimated by the Bio-Rad protein assay method using bovine serum albumin as a standard.
Purification of Kanamycin A. Commercial kanamycin A containing small amounts of kanamycin B (5%) was purified as follows. Kanamycin A (500 mg) in 50 mM phosphate buffer, pH 7.2, was loaded onto CM-Sephadex column (5 x 1.5 cm), pre-equilibrated with the same buffer. The column was washed with 50 ml of equilibration buffer followed by a linear 0 -0.6 M NaCl gradient. Bound antibiotic eluted as two peaks at approximately 0.4 and 0.55 M NaCl (Authentic Kanamycin B sulfate eluted as a single peak at 0.6 M NaCl under these conditions). Kanamycin A containing fractions, eluting at 0.4 M NaCl, were detected and quantitated using a phenol-sulfuric acid method, concentrated by lyophilization, desalted on a Sephadex G-10 column (1.5 x 50 cm) using Milli-Q water and used in kinetic studies.
Measurement of Enzyme activity. Reaction rates were measured spectrophotometrically by following the increase in absorbance at 324 nm due to the reaction between the free sulfhydryl group of CoASH, generated by the enzyme-catalyzed aminoglycoside acylating activity, and 4,4'-dithiopyridine. The reaction was monitored continuously on a UVIKON 943 spectrophotometer and enzyme activities were calculated using a molar absorption coefficient . Assay mixtures contained 100 mM potassium phosphate, pH 7.0, 0.2 mM 4,4'-dithiopyridine, in addition to substrates or inhibitors in a volume of 1 ml. Reactions were initiated by the addition of enzyme and followed at 30°C for 1-2 min. Initial velocity kinetic 8 data were fitted using the programs of Cleland (25 
In equations 
The solvent kinetic isotope effects on V and V/K were determined by measuring the initial velocities using saturating concentrations of acyl-CoA and varying concentrations of aminoglycoside in H 2 O or ca. 98% D 2 O as solvent. Solvent deuterium isotope effects were calculated from the equation:
where, I represents the fraction of isotope and E VK and E V are isotope effects on V/K and V,-1, respectively. (2' Table 1 . The steady-state kinetic parameters for various aminoglycosides at saturating concentrations of acetyl-CoA and propionyl-CoA are also summarized in Table 1 .
RESULTS

Purification and properties of AAC
The structures of the aminoglycosides used are shown in Figure 1 . Aminoglycoside substrates can be divided into two groups on the basis of their kinetic behavior. Seven out of thirteen antibiotics, using acetyl-CoA (eight out of ten using propionyl-CoA) as the second substrate, exhibited linear reciprocal plots at low substrate concentrations but rapidly increasing velocities at higher antibiotic concentrations ( Figure 2 ). This phenomenon termed "substrate activation", has previously been observed with other aminoglycoside acetyltransferases (19, 21) . For substrates exhibiting substrate activation, two pairs of fitted parameters are included in Table 1 . Kinetic mechanism. The initial velocity pattern was determined using sisomicin and acetyl-CoA at five different concentrations of acetyl-CoA and four different concentrations of sisomicin. The resultant double reciprocal plot was intersecting (data not shown), indicating a sequential kinetic mechanism. Alternative aminoglycoside kinetics were determined using propionyl-CoA as the variable substrate at fixed, saturating concentrations of eight different aminoglycosides ( Table 2) . The values of V/K for propionyl-CoA varied modestly (over a 7 fold range), with this change being as the result of changes in both V and K m values for propionylCoA. Alternate acyl coenzyme A kinetics were determined using sisomicin as the variable substrate at a fixed, saturating concentrations of five different coenzyme A derivatives ( Table   2 ). The values of V/K for sisomicin varied over a 2500-fold range, with this change being as the result of changes in both V and K values for sisomicin ( paromomycin, exhibiting relatively low and high K m values, respectively, using both acyl coenzyme A's were used. The solvent kinetic isotope effects on V were 1.7 ± 0.02 and 2.1 ± 0.08 for ribostamycin and paromomycin respectively, when acetyl-CoA was the acyl donor ( Fig. 3) . A value for D 2 OV of 1.49 ± 0.05 was obtained using paromomycin and propionyl-CoA and a value for D 2 OV of 1.66 ± 0.09 was obtained using only the high concentration ribostamycin data and propionyl-CoA (Figure 2 ). The solvent kinetic isotope effects on V/K were identical for paromomycin using either acetyl-CoA or propionyl-CoA (0.98 ± 0.1 and 1.03 ± 0.1, respectively) and for ribostamycin using acetyl-CoA (1.15 ± 0.07). Using just the data obtained using propionyl-CoA at low ribostamycin concentrations (5 -100 µM), the V and V/K solvent kinetic isotope effects were 1.5 ± 0.1 and 1.5 ± 0.2, respectively ( Figure 3 ). The latter is significantly greater than one, the value for the V/K solvent kinetic isotope effect observed in all other cases.
DISCUSSION
From the determined steady state kinetic parameters (Table 1) for the AAC(6') from S. enterica (19) , in contrast to the AAC(6') enzymes from E. coli and E.
faecium (16, 18) .
The AAC(2')-Ic exhibits a very broad specificity with respect to aminoglycosides. All aminoglycosides having a 2'-amino substituent were substrates. Kanamycin A and amikacin (a semisynthetic derivative of kanamycin A) contain hydroxyl groups at the 2' position, but exhibited measurable activity, consistent with the enzyme's unique ability to perform both O- Many of the aminoglycosides exhibited non-linear double reciprocal plots, referred to as 'substrate activation', which has also been observed for AAC(6')-Iy from S. enterica (19) and gentamicin acetyltransferase (21) . Kanamycin B, neomycin B and ribostamycin did not show any substrate activation for acetylation, but did for propionylation, whereas paromomycin and butirosin did not exhibit substrate activation upon propionylation, but did for acetylation. None of the acyl-CoA's displayed substrate activation. There was no single structural feature or substitution that distinguishes between linear and non-linear behavior of aminoglycoside substrates. Such aminoglycoside-dependent shifts from linear to nonlinear kinetics have been proposed to be the result of changes in kinetic mechanism (21), or to substrate-dependent subunit interactions in a dimeric enzyme (19) .
The intersecting initial velocity plots obtained for sisomicin and acetyl-CoA suggests a sequential kinetic mechanism, where both substrates must be bound to the enzyme for catalysis to occur. The sequential kinetic mechanism appears to be universally used by aminoglycoside N-acetyltransferases of all classes studied to date (3, 2' and 6'), although there is no reason, a priori, why a ping-pong kinetic mechanism could not be used. Dead-end inhibition studies were performed to distinguish between the ordered and random addition of substrates. Desulfo-CoA exhibited linear, competitive inhibition versus acetyl-CoA and linear, noncompetitive inhibition versus sisomicin. These data are compatible with the ordered addition of acetyl-CoA followed by sisomicin. Alternate aminoglycoside kinetics is another useful approach to discriminate between various kinetic mechanisms and has been used earlier to determine the kinetic mechanisms of kanamycin 6'-N-acetyltransferase and AAC(6')-Iy (17, 19) . We determined the V/K value of propionyl-CoA at saturating concentrations of eight different aminoglycoside substrates. The determined values of V/K depend on the identity of aminoglycoside used, with the range of values varying some 7-fold. The V/K value for sisomicin was highly dependent on the identity of the acyl-CoA substrate used, with the range varying over 2000-fold. For an ordered sequential mechanism, the V/K value of the first substrate to bind should not be influenced by the identity of the second substrate, but the V/K value of the second substrate to bind will be substantially influenced by the identity of the first substrate. In the present case, there is only a modest effect on the V/K value of propionyl-CoA on the identity of the aminoglycoside substrate, and a much larger effect on the V/K value for sisomicin on the identity of the acyl-CoA substrate. This suggests that the acyl-CoA preferentially binds to the free enzyme, in agreement with the dead-end inhibition data. However, the modest change in the V/K value of propionyl-CoA with aminoglycoside identity requires that there be a degree of randomness in substrate binding, with aminoglycoside substrates being able to bind to both enzyme-acyl-CoA and free enzyme. The independent evaluation of aminoglycoside binding to the free enzyme is being pursued.
Studies of solvent kinetic isotope effects can be a useful tool in the determination of rate-limiting chemical steps and the kinetic mechanism, especially to distinguish between steady-state random and rapid equilibrium random mechanisms. In a rapid equilibrium random kinetic mechanism, the rates of substrate binding and product dissociation are very fast relative to the catalytic step, and equivalent isotope effects must be observed on V and V/K. This is not a requirement for the steady-state random mechanism. Solvent kinetic isotope effects were acetyltransfer to aminoglycosides by an aminoglycoside acetyltransferase. In contrast, in the case of well-studied 6'-N-acetyltransferases, all aminoglycosides bearing 6'-hydroxyl substituents are inhibitors, and exhibit no detectable activity (18, 19) . In the case of the related P. stuartii AAC(2')-Ia enzyme, the enzyme has been shown to perform the O-acetylation of peptidoglycan intermediates (23) , and very recently, the overexpressed and homogeneous enzyme has been shown to be capable of acetylation of aminoglycosides, however, aminoglycosides bearing a 2'-hydroxyl substituent, e.g., kanamycin A and amikacin, were not tested in this study (24) . These data are consistent with a physiological role in peptidoglycan acetylation for the Providencia enzyme, and by extension to the M. tuberculosis enzyme. In support of this idea, clinical resistance to aminoglycosides in M. tuberculosis has been shown to be due to single base substitutions in the 16S rRNA gene or the gene encoding the S12 ribosomal protein, resulting in single amino acid substitutions (26) . Finally, aac(2') genes are universally present in mycobacterial species, and the deduced amino acid sequences are highly homologous (63-79%), yet their presence does not correlate with resistance to aminoglycosides (22) . These data are consistent with the theory that AAC(2') gene products have a yet unidentified physiological role and aminoglycoside acetylation is only a fortuitous secondary activity. Studies to determine the true substrate or substrates for the M. tuberculosis enzyme are being pursued. 
